24.11.2006 |
EN |
Official Journal of the European Union |
C 287/7 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 1.10.2006 to 31.10.2006
(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))
(2006/C 287/03)
— Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|||||||
4.10.2006 |
Abilify |
|
EU/1/04/276/036 |
6.10.2006 |
|||||||
4.10.2006 |
Abilify |
|
EU/1/04/276/036 |
6.10.2006 |
|||||||
6.10.2006 |
Travatan |
|
EU/1/01/199/001-002 |
10.10.2006 |
|||||||
11.10.2006 |
Invirase |
|
EU/1/96/026/001-002 |
13.10.2006 |
|||||||
17.10.2006 |
Cetrotide |
|
EU/1/99/100/001-003 |
19.10.2006 |
|||||||
19.10.2006 |
Zometa |
|
EU/1/01/176/001-006 |
23.10.2006 |
|||||||
19.10.2006 |
Zevalin |
|
EU/1/03/264/001 |
23.10.2006 |
|||||||
20.10.2006 |
Herceptin |
|
EU/1/00/145/001 |
24.10.2006 |
|||||||
20.10.2006 |
PritorPlus |
|
EU/1/02/215/001-012 |
24.10.2006 |
|||||||
20.10.2006 |
Enbrel |
|
EU/1/99/126/001-018 |
24.10.2006 |
|||||||
20.10.2006 |
Caelyx |
|
EU/1/96/011/001-004 |
24.10.2006 |
|||||||
20.10.2006 |
Avonex |
|
EU/1/97/033/001-003 |
24.10.2006 |
|||||||
20.10.2006 |
Faslodex |
|
EU/1/03/269/001 |
24.10.2006 |
|||||||
20.10.2006 |
ViraferonPeg |
|
EU/1/00/132/001-050 |
24.10.2006 |
|||||||
23.10.2006 |
Taxotere |
Aventis Pharma S.A., 20 Avenue Raymond Aron, Antony Cedex 92165, France |
EU/1/95/002/001-002 |
25.10.2006 |
|||||||
23.10.2006 |
PhotoBarr |
|
EU/1/04/272/001-002 |
25.10.2006 |
|||||||
23.10.2006 |
Dynepo |
|
EU/1/02/211/001-005 |
26.10.2006 |
|||||||
24.10.2006 |
PegIntron |
|
EU/1/00/131/001-050 |
25.10.2006 |
|||||||
24.10.2006 |
AVANDIA |
|
EU/1/00/137/002-018 |
26.10.2006 |
|||||||
24.10.2006 |
Aclasta |
|
EU/1/05/308/001-002 |
26.10.2006 |
|||||||
24.10.2006 |
Prometax |
|
EU/1/98/092/001-018 |
26.10.2006 |
|||||||
24.10.2006 |
Invanz |
|
EU/1/02/216/001-002 |
26.10.2006 |
|||||||
24.10.2006 |
Apidra |
|
EU/1/04/285/013-020 |
26.10.2006 |
|||||||
24.10.2006 |
Fuzeon |
|
EU/1/03/252/001-003 |
26.10.2006 |
|||||||
24.10.2006 |
Avandamet |
|
EU/1/03/258/001-022 |
26.10.2006 |
|||||||
26.10.2006 |
Ketek |
|
EU/1/01/191/001-005 |
30.10.2006 |
|||||||
26.10.2006 |
Levviax |
|
EU/1/01/192/001-005 |
30.10.2006 |
|||||||
26.10.2006 |
Actos |
|
EU/1/00/150/001-024 |
30.10.2006 |
|||||||
26.10.2006 |
Glustin |
|
EU/1/00/151/001-022 |
30.10.2006 |
|||||||
26.10.2006 |
Sustiva |
|
EU/1/99/110/001-009 |
30.10.2006 |
|||||||
26.10.2006 |
Stocrin |
|
EU/1/99/111/001-009 |
30.10.2006 |
|||||||
26.10.2006 |
Exelon |
|
EU/1/98/066/001-018 |
30.10.2006 |
|||||||
26.10.2006 |
Helixate NexGen |
|
EU/1/00/144/001-003 |
30.10.2006 |
|||||||
26.10.2006 |
Vfend |
|
EU/1/02/212/001-026 |
30.10.2006 |
|||||||
27.10.2006 |
Pritor |
|
EU/1/98/089/001-019 |
31.10.2006 |
|||||||
27.10.2006 |
Ariclaim |
|
EU/1/04/283/001-007 |
31.10.2006 |
|||||||
27.10.2006 |
Rebetol |
|
EU/1/99/107/001-005 |
31.10.2006 |
|||||||
27.10.2006 |
Remicade |
|
EU/1/99/116/001-003 |
31.10.2006 |
|||||||
27.10.2006 |
Avaglim |
|
EU/1/06/349/001-008 |
31.10.2006 |
|||||||
27.10.2006 |
Viramune |
|
EU/1/97/055/001-003 |
31.10.2006 |
|||||||
27.10.2006 |
Invirase |
|
EU/1/96/026/001-002 |
31.10.2006 |
|||||||
27.10.2006 |
Tracleer |
|
EU/1/02/220/001-005 |
31.10.2006 |
|||||||
30.10.2006 |
FOSAVANCE |
|
EU/1/05/310/001-005 |
1.11.2006 |
|||||||
30.10.2006 |
Lyrica |
|
EU/1/04/279/001-035 |
1.11.2006 |
|||||||
30.10.2006 |
NutropinAq |
|
EU/1/00/164/003-005 |
1.11.2006 |
|||||||
30.10.2006 |
Keppra |
|
EU/1/00/146/001-030 |
3.11.2006 |
|||||||
30.10.2006 |
Noxafil |
|
EU/1/05/320/001 |
2.11.2006 |
|||||||
30.10.2006 |
Posaconazole SP |
|
EU/1/05/321/001 |
2.11.2006 |
|||||||
30.10.2006 |
Nespo |
|
EU/1/01/184/001-068 |
2.11.2006 |
|||||||
30.10.2006 |
Aranesp |
|
EU/1/01/185/001-068 |
1.11.2006 |
|||||||
31.10.2006 |
Lantus |
|
EU/1/00/134/001-037 |
14.11.2006 |
|||||||
31.10.2006 |
Insuman |
|
EU/1/97/030/065-084 |
6.11.2006 |
|||||||
31.10.2006 |
Optruma |
|
EU/1/98/074/001-004 |
6.11.2006 |
|||||||
31.10.2006 |
Evista |
|
EU/1/98/073/001-004 |
6.11.2006 |
|||||||
31.10.2006 |
Telzir |
|
EU/1/04/282/001-002 |
7.11.2006 |
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:
The European Medicines Agency |
7, Westferry Circus, Canary Wharf |
London E14 4HB |
United Kingdom |
(1) OJ L 136 of 30 April 2004, page 1